SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
TEVA

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

Israel · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
39.83+0.41 (+1.05%)
 
Market cap
$46.4B
Analyst consensus
Insider Score
––Not scored
TEVA Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

TEVA Stock Insider Trading Activity

TEVA stock’s insider trading shows 14 sales on the open market for an estimated $21.20M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Savage Brian
Other
Sell2,525$39.15$98.84K 22.3%8,814Sep 18, 2026— Form 4
Savage Brian
Other
Sell314$38.70$12.15K 3.6%8,500Sep 18, 2026— Form 4
MIGNONE ROBERTO
Director
Sell367,600$39.06$14.36M 100%0Sep 18, 2026— Form 4
Savage Brian
Other
Option exercise4,503$34.70$156.25K 39.7%15,842Sep 18, 2026— Form 4
Savage Brian
Other
Sell4,503$38.69$174.22K 28.4%11,339Sep 18, 2026— Form 4
Weiss Amir
Other
Sell6,945$37.61$261.22K 34.7%13,071Aug 21, 2026— Form 4
Weiss Amir
Other
Option exercise2,500$19.61$49.02K 19.1%15,571Aug 21, 2026— Form 4
Weiss Amir
Other
Sell2,500$37.63$94.08K 16.1%13,071Aug 21, 2026— Form 4
Satchi-Fainaro Ronit
Director
Sell415$37.25$15.46K 0.4%111,986Aug 21, 2026— Form 4
Lippman Evan
Other
Sell18,600$36.57$680.29K 42.1%25,591Aug 17, 2026— Form 4
Zaks Tal Zvi
Director
Sell17$34.87$592.71 0.0%73,247Aug 5, 2026— Form 4
Jover Placid
Other
Option exercise12,827—— 189%19,601Aug 3, 2026— Form 4
Jover Placid
Other
Sell12,827$34.88$447.35K 65.4%6,774Aug 3, 2026— Form 4
Hughes Eric A
Other
Option exercise52,744—— 49.0%160,455Aug 3, 2026— Form 4
Hughes Eric A
Other
Sell25,578$34.88$892.05K 15.9%134,877Aug 3, 2026— Form 4
Shields Matthew
Other
Sell9,989$32.19$321.55K 100%0Jun 18, 2026— Form 4
Kalif Eliyahu Sharon
CFO
Sell106,563$34.10$3.63M 61.9%65,621Jun 11, 2026— Form 4
Lichtenstein Chen
Director
Option exercise14,492—— 302%19,296Jun 5, 2026— Form 4
Crane Rosemary A
Director
Option exercise14,492—— 12.8%127,739Jun 5, 2026— Form 4
Elstein Amir
Director
Option exercise14,492—— 0.7%2,118,455Jun 5, 2026— Form 4
LIEBERMAN GERALD M
Director
Option exercise14,492—— 12.5%130,149Jun 5, 2026— Form 4
Nisen Perry
Director
Option exercise14,492—— 13.8%119,807Jun 5, 2026— Form 4
Satchi-Fainaro Ronit
Director
Option exercise14,492—— 14.8%112,401Jun 5, 2026— Form 4
Zaks Tal Zvi
Director
Option exercise14,492—— 24.7%73,264Jun 5, 2026— Form 4
MIGNONE ROBERTO
Director
Option exercise14,492—— 13.8%119,807Jun 5, 2026— Form 4
Francis Richard D
CEO
Sell6,153$34.35$211.36K 0.5%1,177,529Jun 5, 2026— Form 4
Francis Richard D
CEO
Option exercise13,043—— 1.1%1,183,682Jun 5, 2026— Form 4
BARER SOL J
Director
Option exercise21,739—— 5.1%448,011Jun 5, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.